Patent US1980736A successfully refreshed from Google Patents.
Patent US4089971A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4089971A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutically active 2,9-dioxatricyclo[4,3,1,03,7 ]decanes

Assignee: AbbVie Pharmaceuticals GmbH
•
Filing: 1976-10-15
•
Granted: 1978-05-16
•
Expires: 1996-10-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutically active 2,9-dioxatricyclo[4,3,1,03,7] decanes and the process for their production and the production of various intermediates are disclosed. Pharmaceutical compositions containing an effective amount of the novel compounds and a pharmaceutically acceptable carrier are also disclosed.

Inventors

  • 👤 Peter Willibrord Thies
  • 👤 Akiji Asai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 08:21
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/02; C07D493/08; A; A61; A61P; A61P25/00; A61P25/04; A61P3/00; A61P3/04

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 48 words
A compound selected from the group consisting of the 2,9-dioxatricyclo[4,3,1,0 3 ,7 ]decanes of the Formula I: ##STR33## wherein one of R 1 and R 2 is hydrogen and the other is a hydroxy, carboxylic acyloxy or carbamyloxy or R 1 and R 2 taken together denote oxygen.
Claim 2
Dependent Claim 48 words
A compound selected from the group consisting of the 2,9-dioxatricyclo[4,3,1,0 3 ,7 ]decanes of the Formula I: ##STR33## wherein one of R 1 and R 2 is hydrogen and the other is a hydroxy, carboxylic acyloxy or carbamyloxy or R 1 and R 2 taken together denote oxygen.
Claim 3
Dependent Claim 16 words
The compound of claim 1 which is a 4-β-hydroxy-3,10-dimethyl-2,9-dioxatricyclo[4,3,1,0 3 ,7 ]decane of Formula VII: ##STR34##
Claim 4
Dependent Claim 16 words
The compound of claim 1 which is a 3,10-dimethyl-2,9-dioxatricyclo[4,3,1,0 3 ,7 ]decane-4-one of Formula VIII: ##STR35##
Claim 5
Dependent Claim 16 words
The compound of claim 1 which is a 4-α-hydroxy-3,10-dimethyl-2,9-dioxatricyclo[4,3,1,0 3 ,7 ]decane of Formula IX: ##STR36##
Claim 6
Dependent Claim 58 words
A pharmaceutical composition comprising a pharmaceutical carrier and an analgesic and anorectic effective amount of a compound selected from the group consisting of the following structural formula: ##STR37## wherein one of R 1 and R 2 is hydrogen and the other is a hydroxy, carboxylic acyloxy or carbamyloxy or R 1 and R 2 taken together denote oxygen.
Claim 7
Dependent Claim 58 words
A pharmaceutical composition comprising a pharmaceutical carrier and an analgesic and anorectic effective amount of a compound selected from the group consisting of the following structural formula: ##STR37## wherein one of R 1 and R 2 is hydrogen and the other is a hydroxy, carboxylic acyloxy or carbamyloxy or R 1 and R 2 taken together denote oxygen.

References Cited (Backward Citations)

US3812154A Cited
US4016176A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-05-15 1981-11-14 1982-05-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-05-15 1985-11-14 1986-05-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-05-15 1989-11-14 1990-05-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag